Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer, Stage 0”

445 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 445 results

Early research (Phase 1)Study completedNCT02619162
What this trial is testing

Nintedanib+Letrozole in Postmenopausal Women With Breast Cancer: Clinical Trial Safety and Pharmacodynamics

Who this might be right for
Breast Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 25
Large-scale testing (Phase 3)Active Not RecruitingNCT01357772
What this trial is testing

Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

Who this might be right for
Carcinoma, Intraductal, NoninfiltratingRecurrence, Local NeoplasmBreast Neoplasms+1 more
Andrea DeCensi 500
Not applicableStudy completedNCT01293032
What this trial is testing

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituStage II Breast Cancer+4 more
Virginia Commonwealth University 59
Early research (Phase 1)Study completedNCT01009437
What this trial is testing

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 28
Not applicableActive Not RecruitingNCT03495011
What this trial is testing

MRI Characterization of Mammographically Detected DCIS

Who this might be right for
Breast Cancer, Stage 0
University of Washington 122
Very early researchNot Yet RecruitingNCT07671092
What this trial is testing

Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

Who this might be right for
Metastatic Urothelial CarcinomaBreast CancerTNBC - Triple-Negative Breast Cancer+2 more
RayzeBio, Inc. 40
Large-scale testing (Phase 3)Looking for participantsNCT05950945
What this trial is testing

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Daiichi Sankyo 250
Testing effectiveness (Phase 2)Ended earlyNCT00110136
What this trial is testing

St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer

Who this might be right for
Breast CancerHot Flashes
Wake Forest University Health Sciences 9
Not applicableStudy completedNCT04022772
What this trial is testing

Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer

Who this might be right for
Breast CarcinomaBreast Ductal Carcinoma In SituInvasive Breast Carcinoma+1 more
M.D. Anderson Cancer Center 287
Not applicableStudy completedNCT02908178
What this trial is testing

Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ

Who this might be right for
Ductal Carcinoma In Situ
Yale University 28,291
Not applicableActive Not RecruitingNCT03766009
What this trial is testing

Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

Who this might be right for
Breast Cancer Stage 0Breast Cancer Stage IBreast Cancer Stage II+1 more
Alliance for Clinical Trials in Oncology 627
Testing effectiveness (Phase 2)Study completedNCT00090857
What this trial is testing

Letrozole in Preventing Breast Cancer in Postmenopausal Women

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 49
Not applicableActive Not RecruitingNCT03546972
What this trial is testing

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

Who this might be right for
Deleterious BRCA1 Gene MutationDeleterious BRCA2 Gene MutationDuctal Breast Carcinoma In Situ+3 more
M.D. Anderson Cancer Center 51
Post-approval studies (Phase 4)Study completedNCT00742222
What this trial is testing

Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer

Who this might be right for
Breast CancerCarcinomaLumpectomy+1 more
Xoft, Inc. 63
Very early researchWithdrawnNCT01302002
What this trial is testing

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Who this might be right for
Breast Cancer
Instituto Nacional de Cancer, Brazil
Not applicableStudy completedNCT00115505
What this trial is testing

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast Carcinoma
Alliance for Clinical Trials in Oncology 307
Not applicableStudy completedNCT03061175
What this trial is testing

Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy

Who this might be right for
Stage 0 Breast CancerStage I Breast CancerStage IA Breast Cancer+5 more
Rutgers, The State University of New Jersey 94
Large-scale testing (Phase 3)Looking for participantsNCT06380751
What this trial is testing

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
AstraZeneca 788
Not applicableStudy completedNCT02248662
What this trial is testing

Impact of Radiation Therapy on Breast Conservation in DCIS

Who this might be right for
DCIS
Dana-Farber Cancer Institute 3,436
Very early researchWithdrawnNCT02610920
What this trial is testing

Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection

Who this might be right for
Breast NeoplasmCarcinoma, Ductal, BreastCarcinoma, Intraductal, Noninfiltrating
Columbia University
Next Page